API Intermediate MFG Unit for Sale/Investment in Mahad
About Business
The business was established by a seasoned professional with over 26 years of expertise in the API (Bulk Drug) sector. It is actively engaged in the manufacturing of API intermediates and specialty chemicals, operating a dedicated facility for the production of intermediates. With a strong focus on pharmaceutical products and chemicals, the firm emphasizes drug formulation and development within the broader chemical manufacturing industry.
Core Business Activities:
API Intermediates Manufacturing
The company supplies intermediates for active pharmaceutical ingredients (APIs). These serve as the critical building blocks required by drug manufacturers to ensure quality, consistency, and scale in pharmaceutical production.
Specialty Chemicals
The business develops and delivers tailored specialty chemicals that cater to pharmaceutical companies and allied industries, addressing niche requirements with precision and innovation.
Research, Development, and Production Support
The company emphasizes continuous process development, rigorous testing, and quality-controlled manufacturing. Its dedicated facility is designed to meet high industry standards, ensuring compliance and reliability in every stage of production.
Clientele type
Existing Clients Include:
1. Lupin Ltd
2. Intas Pharmaceuticals Ltd
3. Ami Life Sciences Pvt Ltd
4. Harmony Organics Pvt Ltd
5. Agri Life Science Pvt Ltd
6. Aastrid Life Sciences Pvt Ltd
7. Plus 5 reputed traders
Premises
OWNED
Premise Size: 1500 Sq. mtr
Market Value (in INR): 4.50 Cr
1. The property spans a total land area of 1,500 sq. meters with a built-up RCC construction of 734 sq. meters, comprising the Quality Control Department, Production Area, Drying Area, and PD Lab.
2. The building was completed in late 2020.
3. Commercial production commenced in June 2021.
Asking Price Includes
The terms will be discussed with the interested investor.
Asking Price
INR 4.50 Cr
Minimum ticket size
INR 2.50 Cr
Reason
The founder is seeking an exit due to health concerns. However, if an investor is interested in joining as a partner, the founder is open to continuing with the business. The required investment in this case would be ₹2.5 crore. For a complete sale, the asking price is ₹4.5 crore, and the founder is willing to support the buyer post-transaction, including the possibility of working with the company in an employee capacity.
Licenses
EC, MPCB, Factory Licenses, Udyam , GST, Hazardous Waste, CETP
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid Team